MEDI-528, now recognized as enokizumumab, represents a innovative treatment targeting the IGF1R, a key protein linked in multiple skin diseases . Early clinical data suggest notable efficacy for the https://ronaldjpgg275592.wikiinside.com/3980300/enokizumab_a_deep_dive_into_medi_528_and_its_potential